by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Bringing Innovation to Market, Business Lending, Business Loans, Finance, Working Capital
I don’t know whether you caught this story, but at least two companies are now implanting RFID chips tracking subcutaneously–under the skin–of their employees. The chips perform like key-cards/credit cards, allowing access to areas in the facility...
by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – Union Pacific Corp (UNP.N) said on Wednesday it will cut roughly 500 management jobs and 250 railroad workers by mid-September as the No. 1 U.S. railroad continues broader cost-cutting. The layoffs, which represent about 8 percent of its management...
by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Mayor de Blasio ran on a platform of ending income inequality, and had no natural kinship to Wall Street. Four years later, little has changed.
by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Alphabet has acquired AIMatter, a start-up with Android and iOS apps that transform selfies using artificial intelligence. Terms weren’t disclosed. AIMatter CEO Andrei Kulik and a Google spokesperson confirmed the deal to CNBC on Wednesday. The mobile apps will...
by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
A former Bank of America technology consultant used his access to the bank’s internal deal tracking system to share more than 50 trading tips with friends, who generated more than $5 million in illegal trading profits, federal prosecutors said. The worker,...
by synergycap1 | Aug 16, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Overhauling the highly controversial Valeant Pharmaceuticals hasn’t been easy, new CEO Joe Papa acknowledged on Wednesday. “I will say, first and foremost, it’s been a challenging 15 months, to be clear. But we’ve made great progress as a...
